Secondary hyperparathyroidism in HIV patients: Is there any responsibility of highly active antiretroviral therapy?

AIDS

Volumn 25, Issue 11, 2011, Pages 1430-1433

  Daria, Pocaterra ^a   Laura, Carenzi ^a   Elena, Ricci ^a   Davide, Minisci ^a   Monica, Schiavini ^a   Paola, Meraviglia ^a   Maurizio, Bevilacqua ^a   Patrizia, Zucchi ^a   Paolo, Bonfanti ^b   Giuliano, Rizzardini ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b A MANZONI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PARATHYROID HORMONE; PROTEINASE INHIBITOR; TENOFOVIR;

ADULT; AGED; ARTICLE; BONE DENSITY; CROSS-SECTIONAL STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; VITAMIN D DEFICIENCY;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; BONE DENSITY; FEMALE; HIV INFECTIONS; HUMANS; HYPERPARATHYROIDISM, SECONDARY; MALE; MIDDLE AGED; PREVALENCE;

EID: 79959924107     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328349060e     Document Type: Article

References (7)

1. Onen NF, Overton ET. A Review of premature frailty in HIVinfected persons: another manifestation of HIV-related accelerated aging. Curr Aging Sci 2011; 4:33-41.
2. Brown TT, Qaquish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 2006; 20:2165-2174. (Pubitemid 44684707)
3. Triant VA, Brown TT, Lee H, Grinspoon SK. Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large US healthcare system. J Clin Endocrinol Metab 2008; 93:3499-3504.
4. Dao CN, Patel P, Overton ET, Rhame F, Pals SL, Johnson C, et al. Study to understand the natural history of HIV and AIDS in the Era of Effective Therapy (SUN) Investigators. Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin Infect Dis 2011; 52:396-405.
5. Courbebaisse M, Soubebrbielle JC. Phosphocalcic metabolism: regulation and explorations. Nephrol Ther 2011; 7: 118-138.
6. Childs KE, Fishman SL, Constable C, Gutierrez JA, Wyatt CM, Dieterich DT, et al. Short communication: inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users. AIDS Res Hum Retroviruses 2010; 26:855-859.
7. Rosenvinge MM, Gedela K, Copas AJ, Wilkinson A, Sheehy CA, Bano G, et al. Tenofovir-linked hyperparathyroidism is independently associated with the presence of vitamin D deficiency. J Acquir Immune Defic Syndr 2010; 54:496-499.